ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Aug 03, 2015 Elite Pharmaceuticals Completes Enrollment and Dosing for ELI-200 Phase III Efficacy Trial

Jun 16, 2015 Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

Jun 15, 2015 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2015

Jun 11, 2015 CORRECTION -- Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015

Jun 11, 2015 Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015

Jun 09, 2015 Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200

Apr 21, 2015 Elite Pharmaceuticals Announces Launch of Generic Hydroxyzine Tablets

Feb 17, 2015 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2015

Feb 17, 2015 Elite Pharmaceuticals Provides Guidance on Phase III Study for ELI-200

Feb 12, 2015 Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015

6 7 8 9 10 11 12 13 14 15 16

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand